We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

92 hedge funds and large institutions have $585M invested in Abeona Therapeutics in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $9.11M | Put options by funds: $4.3M

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

24% more capital invested

Capital invested by funds: $471M → $585M (+$114M)

5% more funds holding

Funds holding: 88 → 92 (+4)

0.31% more ownership

Funds ownership: 2.78% → 3.09% (+0.31%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
2.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
37
Reduced
22
Closed
12
Calls
$9.11M
Puts
$4.3M
Net Calls
+$4.81M
Net Calls Change
+$1.78M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$42.2M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$40M
3
State Street
State Street
Massachusetts
+$11.4M
4
PC
PointState Capital
New York
+$10.1M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$6.96M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$27.9M
2
PA
Perceptive Advisors
New York
-$16.4M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$11.9M
4
HCM
Highbridge Capital Management
New York
-$6.1M
5
UBS Group
UBS Group
Switzerland
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$114M +$40M +91,640 +48%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$60M +$42.2M +96,537 +181%
State Street
3
State Street
Massachusetts
$48.9M +$11.4M +26,029 +27%
Viking Global Investors
4
Viking Global Investors
Connecticut
$40.8M -$11.9M -27,118 -21%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$40.2M +$6.96M +15,930 +19%
KCM
6
Knoll Capital Management
Florida
$37.8M – – –
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$36M -$1.12M -2,558 -3%
BlackRock
8
BlackRock
New York
$35M +$5.44M +12,441 +17%
BBA
9
Baker Bros. Advisors
New York
$35M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$22.9M +$861K +1,971 +4%
Millennium Management
11
Millennium Management
New York
$15.4M +$849K +1,944 +5%
Deutsche Bank
12
Deutsche Bank
Germany
$10.6M +$5.72M +13,095 +98%
NC
13
Nexthera Capital
New York
$10M +$4.5M +10,292 +70%
PC
14
PointState Capital
New York
$9.21M +$10.1M +23,024 New
CAM
15
Cormorant Asset Management
Massachusetts
$8.79M – – –
Northern Trust
16
Northern Trust
Illinois
$6.25M +$1.5M +3,437 +28%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.9M +$392K +896 +8%
WM
18
WS Management
Florida
$4.45M +$4.86M +11,120 New
Morgan Stanley
19
Morgan Stanley
New York
$3.6M -$2.06M -4,715 -34%
SFM
20
Sphera Funds Management
Israel
$3.57M -$1.26M -2,873 -24%
JP Morgan Chase
21
JP Morgan Chase
New York
$2.85M -$650K -1,487 -17%
RA
22
Royce & Associates
New York
$2.28M – – –
Bank of New York Mellon
23
Bank of New York Mellon
New York
$2.27M -$15.3K -35 -0.6%
Invesco
24
Invesco
Georgia
$2.04M +$2.23M +5,098 New
Allianz Asset Management
25
Allianz Asset Management
Germany
$1.62M -$8.3K -19 -0.5%
1
2 3 4 5

ABEO Hedge Fund Activity: Q2 2018 in Review

92 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2018, worth a combined $585M — up 24% from $471M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ABEO positions and 12 closed out — a net gain of 4 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $42.2M. The largest seller was Citadel Advisors, cutting an estimated $27.9M.

  • 92 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2018, up from 88 in Q1 2018.
  • Funds reported $585M of Abeona Therapeutics stock for Q2 2018, up 24% quarter-over-quarter.
  • 16 funds opened new Abeona Therapeutics positions in Q2 2018 and 12 closed out, a net change of +4 holders.
  • The largest Abeona Therapeutics buyer in Q2 2018 was T. Rowe Price Associates, an estimated $42.2M added.
  • The largest Abeona Therapeutics seller in Q2 2018 was Citadel Advisors, an estimated $27.9M sold.

Based on aggregated 13F filings for Q2 2018.